Medical Devices Series B Investors & VC Firms

660 firms in this list, with a median first check of $730K. 140 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Hitachi Ventures 25 people · Follows rounds	Munich	DE	Seed–Series B	—	+ Add to CRM
M Ventures 9 people · Follows rounds	Los Angeles	US	Seed–Growth	$10.8M	+ Add to CRM
TRAC 8 people	Sonoma	US	Seed–Series B	$250K – $2M	+ Add to CRM
Innovation Industries 25 people · Follows rounds	Amsterdam	NL	Seed–Late Stage	$2.2M – $54M	+ Add to CRM
Kreos Capital 43 people	London	GB	Series A–Late Stage	—	+ Add to CRM
Main Sequence Ventures 26 people · Follows rounds	Sydney	AU	Pre-Seed–Growth	—	+ Add to CRM
Ysios Capital 26 people · Follows rounds	Barcelona	ES	Series A–Late Stage	$5.4M – $21.6M	+ Add to CRM
Artesian 42 people · Leads rounds	Australia	AU	Pre-Seed–Late Stage	—	+ Add to CRM
Artis Ventures 7 people · Leads rounds	San Francisco	US	Seed–Late Stage	$50K – $25M	+ Add to CRM
Abingworth 39 people	London	GB	Pre-Seed–Late Stage	$15M – $30M	+ Add to CRM
Agent Capital 22 people · Leads rounds	Waltham	US	Pre-Seed–Late Stage	—	+ Add to CRM
Fortune Venture Capital 11 people · Follows rounds	Shenzhen	CN	Seed–Late Stage	$425K – $73M	+ Add to CRM
UntroD Capital 5 people · Leads rounds	Tokyo	JP	Pre-Seed–Growth	$772K – $241M	+ Add to CRM
Medicxi 34 people · Follows rounds	London	GB	Pre-Seed–Late Stage	—	+ Add to CRM
HealthCap 30 people	Stockholm	SE	Seed–Growth	—	+ Add to CRM
DOMiNO Ventures 30 people · Leads rounds	Amsterdam	NL	Seed–Series B	$220K – $1.1M	+ Add to CRM
Karista 14 people · Leads rounds	Paris	FR	Pre-Seed–Late Stage	$324K – $5.4M	+ Add to CRM
Safar Partners 20 people	Cambridge	US	Pre-Seed–Late Stage	—	+ Add to CRM
UTEC 1 person · Follows rounds	Tokyo	JP	Pre-Seed–Growth	$3.1M – $78M	+ Add to CRM
aMoon 25 people	Ra'anana	IL	Seed–Late Stage	—	+ Add to CRM
Noro-Moseley Partners 10 people	Atlanta	US	Series A–Late Stage	$5M – $20M	+ Add to CRM
Claret Capital Partners 29 people	London	GB	Series A–Late Stage	—	+ Add to CRM
Novartis Venture Fund 25 people · Leads rounds	Basel	CH	Pre-Seed–Late Stage	$5M – $25M	+ Add to CRM
EcoR1 Capital 17 people	San Francisco	US	Seed–Late Stage	—	+ Add to CRM